Miraten 100ml Syrup is indicated for non-productive cough, whooping cough, pre-post operative cough, and cough suppression.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Butamirate Citrate is a cough suppressant medication used to treat dry cough. Dry cough, characterized by a tickly sensation and the absence of mucus production, occurs when the body attempts to clear irritants like allergens, mucus, or smoke from the airways.
The active ingredient in Butamirate Citrate, Butamirate, is classified as an anti-tussive drug. It functions by inhibiting the transmission of nerve signals from the brain's cough center to the muscles responsible for coughing, thereby reducing the urge to cough.
While using Butamirate Citrate, some individuals may experience side effects such as nausea, vomiting, drowsiness, dizziness, skin rash, and stomach pain. Typically, these side effects are mild and temporary, resolving without medical intervention.
It is essential to use Butamirate Citrate according to your doctor's instructions. Your doctor will determine the appropriate dosage based on the severity of your condition.
Avoid using Butamirate Citrate if you are allergic to it or any of its components. Before initiating Butamirate Citrate treatment, inform your doctor about any existing liver or kidney disease and disclose all other medications you are currently taking. If you are pregnant or breastfeeding, consult your doctor before using Butamirate Citrate to ensure its safety for you and your baby.
It is advisable to refrain from consuming alcohol while using Miraten 100ml Syrup, as it may exacerbate your condition.
If you are pregnant or planning to become pregnant, it is essential to inform your doctor before starting treatment. Your doctor will weigh the potential benefits against the risks before prescribing this medication.
If you are breastfeeding, notify your doctor before using Miraten 100ml Syrup. Your doctor will assess whether the benefits of treatment outweigh the potential risks to the infant.
Some patients may experience dizziness while taking Miraten 100ml Syrup, which could impair their ability to drive or operate machinery. It is recommended to avoid such activities until you are fully alert.
There is limited information available regarding the use of Miraten 100ml Syrup in patients with liver impairment. If you have liver problems, consult your doctor before using Miraten 100ml Syrup.
Limited data are available on the use of BUTAMIRATE in individuals with kidney issues. If you have kidney problems, it is advisable to consult your doctor before using Miraten 100ml Syrup.
Butamirate acts centrally as a cough suppressant in non-productive cough.
Tolerance of Miraten is generally good. Adverse reactions such as rash, nausea, diarrhea, and vertigo have been observed in rare cases, resolving after dose reduction or treatment withdrawal.
Miraten is indicated for relieving dry (non-productive) coughs, including those caused by recent viral infections. It is also used for pre-and post-operative cough sedation in patients undergoing surgical procedures and bronchoscopy. Additionally, it can be used in the acute cough of any etiology, whooping cough, and cough due to acute lower respiratory tract infections (tracheitis, laryngitis, bronchitis), etc.
Butamirate Citrate acts directly on the brain's cough center to suppress cough. It is safe and non-sedating, not chemically or pharmacologically related to opium alkaloids. Butamirate Citrate is rapidly and completely absorbed after oral administration, with maximum concentration reached within 9 hours with sustained-release tablets. It is highly protein-bound, with a plasma elimination half-life of about 13 hours. The active metabolites of Butamirate Citrate also have antitussive action.
Butamirate Citrate syrup:
An accidental overdose of Miraten may cause symptoms such as drowsiness, nausea, vomiting, diarrhea, loss of balance, and hypotension. Standard emergency procedures should be followed.
Concomitant use with expectorants should be avoided.
Hypersensitivity to butamirate.
Butamirate Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. In the absence of data on the elimination of the active substance in breast milk, the benefits of Butamirate Citrate administration during breastfeeding should be carefully weighed against the risks.
Miraten suppresses the cough reflex, so concomitant use with expectorants should be avoided. Prolonged cough should prompt consultation with a doctor.
Store away from light and moisture, below 30°C. Keep out of reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.